sclc
Showing 1 - 25 of 720
Molecular Analysis and Treatment Options of SCLC
Recruiting
- Small-cell Lung Cancer
- +4 more
-
Shanghai, ChinaShanghai Chest Hospital
Jul 6, 2023
Nomogram Predicting Survival in Chinese SCLC Patients
Completed
- Small Cell Lung Cancer
- initial chemotherapy response
- (no location specified)
Jan 8, 2023
SCLC,Extensive Stage Trial in Hangzhou (Thoracic radiotherapy)
Recruiting
- SCLC,Extensive Stage
- Thoracic radiotherapy
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 14, 2022
Small-cell Lung Cancer Trial in Guangzhou (Serplulimab)
Recruiting
- Small-cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Perople's Hospital
Jul 20, 2023
Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)
Not yet recruiting
- Small Cell Lung Cancer Extensive Stage
- quaratusugene ozeplasmid
- atezolizumab
- (no location specified)
Jan 19, 2023
SCLC,Extensive Stage Trial in Omaha (RYZ101 Dose Level 1, RYZ101 Dose Level 2, RYZ101 Dose Level 3)
Recruiting
- SCLC,Extensive Stage
- RYZ101 Dose Level 1
- +6 more
-
Omaha, NebraskaNebraska Cancer Specialists
Nov 18, 2022
Safety and Efficacy of Zepzelca™ Injection
Recruiting
- SCLC
-
Seoul, Korea, Republic ofSeoul National University Boramae Medical Center
Aug 28, 2023
Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
- Trilaciclib
- +2 more
- (no location specified)
May 22, 2023
Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)
Not yet recruiting
- Extensive Stage Lung Small Cell Carcinoma
- Stage IV Lung Cancer
- Carboplatin
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Oct 25, 2023
Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC
Completed
- Small Cell Lung Cancer
- atezolizumab
-
Chalon-sur-Saône, France
- +1 more
Jan 5, 2023
Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)
Recruiting
- Small Cell Lung Cancer
- AL8326 low dose group
- +2 more
-
Saint Louis, MissouriSiteman cancer center, Washington University
Nov 1, 2022
Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for
Not yet recruiting
- Limited-stage Small Cell Lung Cancer (LS-SCLC)
- Tifcemalimab injection
- +3 more
-
Jinan, Shandong, ChinaShandong Cancer Hospital & Institute
Oct 18, 2023
Molecular Subtyping of Extensive Stage Small Cell Lung Cancer
Recruiting
- SCLC,Extensive Stage
- PD-(L)1 antibody immunotherapy
-
Beijing, Beijing, ChinaPeking University Cancer Hospital & Institute
Jul 3, 2023
EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)
Recruiting
- EGFR-Mutated Non-Small-Cell Lung Carcinoma
- Small Cell/Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer (ES-SCLC)
- (no location specified)
Sep 19, 2023
Small Cell Lung Cancer (SCLC) Trial in Guangzhou (Anlotinib Tislelizumab Irinotecan)
Recruiting
- Small Cell Lung Cancer (SCLC)
- Anlotinib Tislelizumab Irinotecan
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Traditional Chinese Medicine
Jun 30, 2022
Extensive Stage Small Cell Lung Cancer Trial (HLX10 + chemo (carboplatin-etoposide), Atezolizumab + chemo
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer
- HLX10 + chemotherapy (carboplatin-etoposide)
- Atezolizumab + chemotherapy (carboplatin-etoposide)
- (no location specified)
Jul 19, 2022
Reveal Patterns of Presentation, Management and Outcome of SCLC
Recruiting
- Lung Cancer
-
Dammam, Saudi Arabia
- +2 more
Jul 25, 2022
Small Cell Lung Cancer Extensive Stage Trial (Pembrolizumab, Plinabulin plus Etoposide and Platinum)
Not yet recruiting
- Small Cell Lung Cancer Extensive Stage
- Pembrolizumab, Plinabulin plus Etoposide and Platinum
- (no location specified)
Feb 15, 2023